US BioTec Inc
OTC:USBC
Balance Sheet
Balance Sheet Decomposition
US BioTec Inc
US BioTec Inc
Balance Sheet
US BioTec Inc
| Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
4
|
12
|
13
|
8
|
3
|
9
|
|
| Cash Equivalents |
4
|
12
|
13
|
8
|
3
|
9
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
4
|
12
|
13
|
8
|
3
|
10
|
|
| PP&E Net |
0
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
115
|
|
| Total Assets |
5
N/A
|
13
+175%
|
14
+7%
|
8
-40%
|
4
-56%
|
125
+3 313%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
0
|
0
|
1
|
|
| Short-Term Debt |
4
|
9
|
2
|
3
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
6
|
11
|
4
|
5
|
5
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
24
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
12
+77%
|
4
-67%
|
5
+16%
|
6
+29%
|
28
+380%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
56
|
81
|
101
|
122
|
139
|
163
|
|
| Additional Paid In Capital |
54
|
83
|
111
|
126
|
136
|
260
|
|
| Total Equity |
2
N/A
|
1
N/A
|
10
+694%
|
4
-62%
|
2
N/A
|
97
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
13
+175%
|
14
+7%
|
8
-40%
|
4
-56%
|
125
+3 313%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
3
|
388
|
|
| Preferred Shares Outstanding |
3
|
3
|
3
|
3
|
0
|
0
|
|